- Release Date: 24/02/25 08:06
- Summary: Paradigm Secures Ethics Approval for Phase 3 Trial
- Price Sensitive: Yes
- Download Document 147.26KB
- Forums
- ASX - By Stock
- PAR
- Ann: Paradigm Secures Ethics Approval for Phase 3 Trial
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
1.64%
!
30.0¢

Ann: Paradigm Secures Ethics Approval for Phase 3 Trial
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.0¢ |
Change
-0.005(1.64%) |
Mkt cap ! $121.2M |
Open | High | Low | Value | Volume |
31.0¢ | 31.0¢ | 30.0¢ | $40.19K | 130.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 227668 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.5¢ | 17996 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 229318 | 0.300 |
21 | 451852 | 0.295 |
20 | 281212 | 0.290 |
11 | 63534 | 0.285 |
10 | 243485 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.305 | 9167 | 2 |
0.310 | 40369 | 10 |
0.315 | 35252 | 7 |
0.320 | 60139 | 7 |
0.325 | 102163 | 7 |
Last trade - 10.57am 22/08/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, MD & CEO
Michael Thurn
MD & CEO
SPONSORED BY The Market Online